Corcept Therapeutics
CORT
#2425
Rank
ยฃ5.63 B
Marketcap
ยฃ51.46
Share price
-3.25%
Change (1 day)
-9.91%
Change (1 year)

EPS for Corcept Therapeutics (CORT)

EPS in 2026 (TTM): ยฃ1.13

According to Corcept Therapeutics 's latest financial reports the company's current EPS (TTM) is ยฃ1.14. In 2025 the company made an earnings per share (EPS) of ยฃ0.71 a decrease over its 2024 EPS that were of ยฃ1.02.

EPS history for Corcept Therapeutics from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)ยฃ1.1358.09%
2025ยฃ0.71-30.37%
2024ยฃ1.02
2022ยฃ0.72-2.06%
2021ยฃ0.745.43%
2020ยฃ0.7010.84%
2019ยฃ0.6327.69%
2018ยฃ0.49-42.48%
2017ยฃ0.86

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ5.07 345.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ3.99 250.00%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
ยฃ0.54-52.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ23.45 1,959.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ0.75-33.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ3.43 201.33%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-ยฃ0.09869-108.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-ยฃ0.01518-101.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-ยฃ0.06833-106.00%๐Ÿ‡บ๐Ÿ‡ธ USA